Healthy volunteers [targeted indication: chronic obstructive pulmonary disease (COPD)] research hub

A randomised, double-blind, placebo-controlled trial to assess the effects of EP395 following an inhaled endotoxin challenge in healthy adults

This study is testing a new medicine, EP395, in healthy adults. Researchers want to see if it can help protect the lungs from irritation, similar to what happens in conditions like COPD. It's an early-stage study to understand how the medicine works.